A study on Ayurvedic etiopathology and treatment of Bronchial Asthma and effect of shwasahara drugs in the management of Bronchial asthma and Cardiac Asthma

A Conceptual study on Nidana and Chikitsa of Shwasa and Role of Shwasahara Dashemani on Shwasa Vis-a-vis Bronchial Asthma and Cardiac Asthma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032624

Enrollment

Registered

2021-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma Health Condition 2: J454- Moderate persistent asthma

Interventions

Intervention1: Shwasahara Dashemani Kashaya With standard treatment protocol.: Bronchial Asthma Group 2-shwasahara dashemani kashaya, 30 ml- 30 DAYS Cardiac Asthma-shwasahara dashemani kashaya With s

Eligibility

Inclusion criteria

Inclusion criteria: 1.subjects with the diagnosed case of Bronchial Asthma 2.For Bronchial Asthma age group of 18 to 60yrs 3.subjects with the diagnosed case of cardiac Asthma (LVF, EF-35-39%) 4.For Bronchial Asthma age group of 40 to 60yrs

Exclusion criteria

Exclusion criteria: 1.severe life-threatening type of Bronchial Asthma (status Asthmatics)associated with Complications. 2.severe life-threatening type of LVF (ejection fraction less than 35%)associated with Complications

Design outcomes

Primary

Measure	Time frame
Reduction of Dyspnea , quality of life improvement Timepoint: 4weeks	—

Secondary

Measure	Time frame
Relive of other symptoms of ShwasaTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr ROOPA M R

Governament Ayurveda medical college and Hospital,Mysuru

vachate37@gmail.com9448150212

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026